Author

Mario Mazic

Medical University of ViennaORCID 0000-0002-2385-1866Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Markus HengstschlägeriD· 2 shared Paul EtteliD· 2 shared Piyal SahaiD· 2 shared Thomas WeichhartiD· 2 shared Aglaja KopfiD· 1 shared Andrea VogeliD· 1 shared Anna Gschwendtner· 1 shared Anna KoreniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Markus HengstschlägerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Alternatively polarized neutrophils metabolically restrain macrophage-driven inflammation

Paul Ettel, Jayne Louise Wilson, Piyal Saha, Mario Mazic, Aglaja Kopf, Kveta Brazdilova, Georg Stary, Ivan Melikhov, Anne Miller, Jadwiga Jabłońska, Markus H. Hoffmann, Gernot Schabbauer, Markus Hengstschläger, Thomas Weichhart

This study identifies an arginine-dependent metabolic mechanism by which alternatively polarized neutrophils restrain macrophage-driven inflammation in mouse models and human diseases.

bioRxiv · Oct 6, 2026 · PreprintImmunology

A cell death screen identifies macrophage-depleting agents with therapeutic potential

Stephan Forisch, Paul Ettel, Manuela Träger, Mario Mazic, Hannah K. Mayr, Andrea Vogel, Piyal Saha, Lovro Davidovski, Roko Sango, Velina S. Atanasova, Anna Gschwendtner, Christoph Trenk, Herwig Peter Moll, Emilio Casanova, Helmut Dolznig, , Thomas Weichhart

This study identifies three small molecule inhibitors that reduce macrophage survival and viability, showing therapeutic potential in models of inflammation and cancer.

bioRxiv · Sep 23, 2026 · PreprintImmunology